H2 Biopharma buyout by Aurora Cannabis finalized at USD 25 million
Date: 2017-11-24   Author: Saipriya Iyer  Category: #news

H2 Biopharma buyout by Aurora Cannabis finalized at USD 25 million

Aurora Cannabis Incorporation, a Canada based medical marijuana producer, has reportedly declared that it is all set to acquire the reputed Quebec based late phase ACMPR applicant, H2 Biopharma Incorporation, through a binding stock buyout transaction. According to the reliable sources, the former is expected to make a total payment of nearly USD 25 million for the proposed acquisition, including the closing as well as milestone payments. The buyout apparently, is expected to mark Aurora’s fourth production facility in Canada and the second facility in Quebec along with its 40,000 sq. feet production facility – called the “Aurora Vie” on Montreal island. It has also been stated that this acquisition deal is subject to the regulatory approval by the Toronto Stock Exchange.

If reports are to be believed, H2 Biopharma Incorporation is on the verge of completing its purpose-built cannabis production facility spread over 48000 sq. feet, which is located in the vicinity of Montreal and the Pierre-Elliott Trudeau International Airport. This Lachute facility, which is anticipated to produce nearly 4,500 kg of high quality marijuana each year, reportedly has the access to water and inexpensive power supply supported by better infrastructure. H2’s acquisition, thus, will help Aurora to further expand the capacity of this production facility and improve its overall marijuana output, cite renowned industry analysts.

Apparently, it has been observed that there is an excessive demand for legalized & regulated cannabis items across the domestic as well as globally evolving markets. By means of leveraging its current financial position, outstanding liquidity record, in conjunction with its long years of experience to create technologically modernized cannabis units, Aurora, say experts, is anticipated to achieve top-notch output and asset distribution at an attractive price-value. Furthermore, this deal has also been declared to fulfill the regional as well as global demand for cannabis products, cite reports.  



About Author


Saipriya Iyer

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

More from Saipriya


Post Recommendents

Melanocyte Protein PMEL Market Size – Advanced Technologies & Growth Opportunities in Global Industry By 2026
Author: Ashwin Naphade

Global Melanocyte Protein PMEL Market report contains all study material about overview, growth, demand and forecast research report in all over the world. This report offers some penetrating overview and solution in the complex world Global Melan...


Anaplastic Astrocytoma Drug Market Presents an Overall Analysis, Trends and Forecast to 2025
Author: Ashwin Naphade

Global Anaplastic Astrocytoma Drug Market, 2020-2025 Research Report provides crucial statistics on the market status of the Global Anaplastic Astrocytoma Drug manufacturers and is a respected source of guidance and direction for companies and ind...


Ultrasonic Corneal Pachymeter Market Shares, Strategies and Forecast Worldwide, 2020-2025
Author: Ashwin Naphade

For overview analysis, MarketStudyReport.com offers Global Ultrasonic Corneal Pachymeter Market research report with basic information including definition, classification, application, industry chain structure, industry overview, policy analysis,...